DeepX Diagnostics Inc. announced that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration for teledermatology screening of suspect skin cancer lesions in the United States.
DeepX Diagnostics Inc. announced that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration for teledermatology screening of suspect skin cancer lesions in the United States.